Background/aims To introduce a novel ab interno 360° trabeculotomy for treating primary congenital glaucoma (PCG) and juvenile open angle glaucoma (JOAG) and report preliminary results. Methods A ...

Patients with contraindications to SLT are excluded as are patients with angle closure glaucoma, congenital or developmental glaucoma, secondary glaucoma (except exfoliative or pigmentary glaucoma) or ...

Use of nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs) is associated with an increased risk for primary ...

Nicox completed the Denali Phase 3 trial for NCX 470, targeting open-angle glaucoma and ocular hypertension. NCX 470 combines ...

Magnetically steered mesenchymal stem cells significantly lowered intraocular pressure for 9 months in mice, motivating the translation of this technology for the treatment of glaucoma.

Glaucoma UK - the UK’s only charity solely dedicated to raising awareness of and supporting people living with glaucoma - has developed an online quiz to help people understand their risk.

Each company attacks the quantum challenge from a different angle, reducing single-technology risk.

Patients with glaucoma using fixed combination therapy may experience faster presbyopia progression than those using monotherapy.